Publications in collaboration with researchers from Stanford University School of Medicine (10)

2023

  1. Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

    Nature Communications, Vol. 14, Núm. 1

  2. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

    Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222

2020

  1. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

    British Journal of Cancer, Vol. 123, Núm. 5, pp. 793-802

2019

  1. Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma

    Nature Medicine, Vol. 25, Núm. 11, pp. 1783-1795

2018

  1. Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

    Journal of Thoracic Oncology, Vol. 13, Núm. 2, pp. 165-183

  2. Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies

    Clinical Lung Cancer, Vol. 19, Núm. 4, pp. 331-339

  3. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

    Mayo Clinic Proceedings, Vol. 93, Núm. 3, pp. 307-320

  4. Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

    Annals of Oncology, Vol. 29, Núm. 8, pp. 1701-1709

2016

  1. Clinicopathologic features of advanced squamous NSCLC

    Journal of Thoracic Oncology, Vol. 11, Núm. 9, pp. 1411-1422

  2. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment

    Journal of Thoracic Oncology, Vol. 11, Núm. 12, pp. 2066-2081